Editing Medusa Pharmaceuticals
Revision as of 22:30, 2 March 2022 by Rachel (talk | contribs) (Created page with "Reinvigorating antibiotics by repurposing approved drugs to overcome AMR '''About Medusa Pharmaceuticals:''' Medusa Pharmaceuticals is an Imperial College London spin-out based on a serendipitous discovery: synergy between an aminoglycoside antibiotic and an alkylating agent, able to overcome antimicrobial resistance, treating lethal infections. We are developing a discovery platform to generate a powerful suite of broadly targeting combination therapeutics optimised...")
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Retrieved from ‘https://stockhub.co/research/Medusa_Pharmaceuticals’